| Coronavirus goes viral: quantifying the COVID-19 misinformation epidemic on Twitter R Kouzy, J Abi Jaoude, A Kraitem, MB El Alam, B Karam, E Adib, J Zarka, ... Cureus 12 (3), 2020 | 1107 | 2020 |
| Gut microbiome diversity as an independent predictor of survival in cervical cancer patients receiving chemoradiation. Journal of Clinical Oncology 38 (15), 6036-6036, 2020 | 94* | 2020 |
| Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring LE Colbert, MB El Alam, R Wang, T Karpinets, D Lo, EJ Lynn, TA Harris, ... Cancer Cell 41 (11), 1945-1962. e11, 2023 | 71 | 2023 |
| & Baddour, K.(2020). Coronavirus goes viral: quantifying the COVID-19 misinformation epidemic on Twitter R Kouzy, J Abi Jaoude, A Kraitem, MB El Alam, B Karam, E Adib Cureus 12 (3), e7255, 0 | 36 | |
| A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers MB El Alam, TT Sims, R Kouzy, GWG Biegert, JABI Jaoude, TV Karpinets, ... PloS one 16 (3), e0247905, 2021 | 27 | 2021 |
| Yoshida-Court, K.; Wu, X.; Biegert, GWG; Delgado Medrano, AY; et al. Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving … TT Sims, MB El Alam, TV Karpinets, S Dorta-Estremera, VL Hegde, ... Commun. Biol 4, 237, 2021 | 27 | 2021 |
| Characteristics of the multiplicity of randomized clinical trials for coronavirus disease 2019 launched during the pandemic R Kouzy, J Abi Jaoude, CJG Garcia, MB El Alam, CM Taniguchi, ... JAMA Network Open 3 (7), e2015100-e2015100, 2020 | 22 | 2020 |
| HPV-related anal cancer is associated with changes in the anorectal microbiome during cancer development JH Elnaggar, VO Huynh, D Lin, RT Hillman, CO Abana, MB El Alam, ... Frontiers in immunology 14, 1051431, 2023 | 16 | 2023 |
| Diversity and composition of gut microbiome of cervical cancer patients: Do results of 16S rRNA sequencing and whole genome sequencing approaches align? G Biegert, MB El Alam, T Karpinets, X Wu, TT Sims, K Yoshida-Court, ... Journal of microbiological methods 185, 106213, 2021 | 16 | 2021 |
| Cervicovaginal microbiota profiles in precancerous lesions and cervical cancer among Ethiopian women B Teka, K Yoshida-Court, E Firdawoke, Z Chanyalew, M Gizaw, ... Microorganisms 11 (4), 833, 2023 | 13 | 2023 |
| Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers LE Colbert, MB El, EJ Lynn, J Bronk, TV Karpinets, X Wu, BV Chapman, ... Cancer immunology research 10 (2), 259-271, 2022 | 13 | 2022 |
| Microbiome dynamics during chemoradiation therapy for anal cancer D Lin, MB El Alam, J Abi Jaoude, R Kouzy, JL Phan, JH Elnaggar, ... International Journal of Radiation Oncology* Biology* Physics 113 (5), 974-984, 2022 | 12 | 2022 |
| Patient-reported GI outcomes in patients with anal cancer receiving modern chemoradiation R Kouzy, J Abi Jaoude, D Lin, MB El Alam, BD Minsky, EJ Koay, P Das, ... JCO oncology practice 16 (12), e1524-e1531, 2020 | 11 | 2020 |
| Exclusion of older adults in COVID-19 clinical trials J Abi Jaoude, R Kouzy, MB El Alam, V Subbiah, CM Taniguchi, EB Ludmir, ... Mayo Clinic Proceedings 95 (10), 2293-2294, 2020 | 11 | 2020 |
| Patient-reported outcome measures in pancreatic cancer receiving radiotherapy R Kouzy, J Abi Jaoude, D Lin, ND Nguyen, MB El Alam, EB Ludmir, ... Cancers 12 (9), 2487, 2020 | 9 | 2020 |
| Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancer TT Sims, GWG Biegert, D Ramogola-Masire, K Ngoni, T Solley, MS Ning, ... International Journal of Gynecological Cancer 30 (8), 1151-1156, 2020 | 9 | 2020 |
| Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure TV Karpinets, X Wu, T Solley, MB El Alam, TT Sims, K Yoshida-Court, ... BMC cancer 22 (1), 945, 2022 | 8 | 2022 |
| Incidence and impact of proportional hazards violations in phase 3 cancer clinical trials. T Lin, A Koong, C Lin, J Abi Jaoude, R Patel, R Kouzy, MB El Alam, ... Journal of Clinical Oncology 40 (16_suppl), 1561-1561, 2022 | 4 | 2022 |
| Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancer K Yoshida-Court, TV Karpinets, A Mitra, TN Solley, S Dorta-Estremera, ... Plos one 18 (1), e0279590, 2023 | 3 | 2023 |
| Proportional hazards violations in phase III cancer clinical trials: a potential source of trial misinterpretation TA Lin, ZR McCaw, A Koong, C Lin, J Abi Jaoude, R Patel, R Kouzy, ... Clinical Cancer Research 30 (20), 4791-4799, 2024 | 2 | 2024 |